EliA SmDP Well, Article Number 14-5624-01 Product Usage: EliA SmDP is intended for the in vit...

FDA Recall #Z-0697-2016 — Class II — December 28, 2015

Recall #Z-0697-2016 Date: December 28, 2015 Classification: Class II Status: Terminated

Product Description

EliA SmDP Well, Article Number 14-5624-01 Product Usage: EliA SmDP is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to Sm in human serum and plasma (EDTA, citrate) as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE) in conjunction with other laboratory and clinical findings. EliA SmDP uses the EliA IgG method on the instruments Phadia 100 and Phadia 250.

Reason for Recall

All equivocal and positive results (greater or equal 7 EliA U/ml) on EliA SmDP well lot 0018 may be incorrect and must be considered invalid. Patient samples in complaint investigations caused unspecific signals up to 22 U/ml on EliA SmDP well lot 0018. The nonspecific signals are not caused by anti-Sm antibodies, nor by streptavidin antibodies.

Recalling Firm

Phadia Ab — Uppsala, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

76

Distribution

US Nationwide in the states of NC, GA, NJ, NY, PA, TX, IL, MI, MT, NM, and OR.

Code Information

Product number: 14-5624-01 Lot: 0018 Exp date: 11/30/2016

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated